VIJAYA.BO
Vijaya Diagnostic Centre LimitedExplain this page
Arphra AIPlain-English read on Vijaya Diagnostic Centre Limited’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
A snapshot of the latest fiscal year’s margins, returns on capital, balance-sheet strength and efficiency, computed from the income statement, balance sheet and cash-flow rows. Source income / balance / cash_flow.
Valuation multiples
| In USD | FY 2026 |
|---|---|
| Headline | |
| Market cap | $91.02B |
| Enterprise value | $94.85B |
| Multiples | |
| P / E | — |
| P / B | — |
| EV / EBITDA | — |
| EV / Sales | 11.65 |
| EV / FCF | 107.94 |
| Yields | |
| Earnings yield | +1.90% |
| Free cash flow yield | +0.97% |
| Dividend yield | — |
Profitability
| In USD | FY 2026 |
|---|---|
| Margins | |
| Gross margin | +88.37% |
| Operating margin | +30.10% |
| EBITDA margin | +43.94% |
| EBIT margin | +32.66% |
| Pre-tax margin | +28.58% |
| Net margin | +21.24% |
| Cost structure | |
| Cost of revenue / sales | +11.63% |
| R&D intensity | 0.00% |
| SG&A intensity | 0.00% |
| Effective tax rate | +25.66% |
Returns on capital
| In USD | FY 2026 |
|---|---|
| Returns | |
| Return on equity (ROE) | +18.07% |
| Return on assets (ROA) | +11.48% |
| Return on capital (ROC) | +17.77% |
| Return on invested capital (ROIC) | +12.54% |
| Asset turnover | +54.03% |
| DuPont · ROE decomposition | |
| Net margin | +21.24% |
| Asset turnover (× revenue / assets) | +54.03% |
| Equity multiplier (× assets / equity) | +157.45% |
Activity & efficiency
| In USD | FY 2026 |
|---|---|
| Turnover | |
| Asset turnover | 0.54 |
| Fixed-asset turnover | 0.84 |
| Inventory turnover | 19.35 |
| Receivables turnover | 39.03 |
| Payables turnover | 2.52 |
| Days outstanding | |
| Days sales outstanding (DSO) | 9.35 |
| Days inventory outstanding (DIO) | 18.86 |
| Days payables outstanding (DPO) | 144.80 |
| Cash conversion cycle | -116.59 |
Cash flow quality
| In USD | FY 2026 |
|---|---|
| Operating CF / Net income | 1.56 |
| FCF / Net income | 0.51 |
| FCF margin | +10.79% |
| OCF margin | +33.23% |
| CapEx / Revenue | +22.44% |
| CapEx / D&A | 1.99 |
| Stock-based comp / Revenue | +0.21% |
Per-share & shareholder yield
| In USD | FY 2026 |
|---|---|
| EPS · diluted | 16.79 |
| EPS · basic | 16.81 |
| Book value / share | 92.91 |
| Tangible BV / share | 79.27 |
| Sales / share | 79.03 |
| Operating CF / share | 26.26 |
| Free cash flow / share | 8.53 |
| Dividends / share | 1.99 |
| Payout ratio | +11.88% |
| Retention ratio | +88.12% |
Growth
| In USD | FY 2026 | CAGR |
|---|---|---|
| Top-line | ||
| Revenue · YoY | — | — |
| Gross profit · YoY | — | — |
| Profit | ||
| Operating income · YoY | — | — |
| EBITDA · YoY | — | — |
| Net income · YoY | — | — |
| Operating | ||
| EBIT · YoY | — | — |
| R&D · YoY | — | — |
| Per-share | ||
| EPS · diluted · YoY | — | — |
| EPS · basic · YoY | — | — |
Credit & leverage
| In USD | FY 2026 |
|---|---|
| Leverage | |
| Total debt | $4.23B |
| Net debt | $3.83B |
| Net debt / EBITDA | 1.07 |
| Debt / equity | 0.44 |
| Debt / assets | +28.04% |
| Equity / assets | +63.51% |
| Coverage | |
| EBITDA / interest expense | 10.77 |
| Operating income / interest | 7.38 |
| Interest expense | $332.31M |
| Liquidity | |
| Current ratio | 2.60 |
| Quick ratio | 2.50 |
| Cash ratio | 0.32 |
| Working capital | $1.98B |
| Working capital / revenue | +24.32% |
Historical multiples · μ ± σ bands
3 fiscal-year-end observations from key_metrics. Mean is dashed; light-green band is ±1σ, light-red band ±2σ. The dot marks the most recent value; the cheap / fair / rich verdict uses z-score against the issuer's own history (yields inverted — a high yield is cheap).
Sourced from key_metrics + financial_ratios (loaded by load_fundamentals_extended.py).
| Metric | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| P / E | — | — | — |
| P / B | — | — | — |
| EV / EBITDA | — | — | — |
| EV / Sales | 11.65x | 15.09x | 12.77x |
| Earnings yield | 1.9% | 1.4% | 1.8% |
| FCF yield | 1.0% | 1.3% | 1.4% |
| Metric | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Gross margin | — | — | — |
| Operating margin | — | — | — |
| Net margin | — | — | — |
| ROE | 18.1% | 18.0% | 18.1% |
| ROA | 11.5% | 11.2% | 12.1% |
| ROIC | 13.0% | 13.0% | 13.3% |
| Metric | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Debt / equity | — | — | — |
| Net debt / EBITDA | 1.07 | 0.94 | 1.00 |
| Interest coverage | — | — | — |
| Current ratio | 2.60x | 1.89x | 2.90x |
| Quick ratio | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).